Research and Development Agreements - Schedule of Deferred Revenue and Accounts Receivable Balances from the Research and Development Agreements (Detail) - USD ($) $ in Thousands |
Dec. 31, 2019 |
Dec. 31, 2018 |
|---|---|---|
| Contract Assets | ||
| Accounts receivable from related party | $ 408 | $ 240 |
| Contract Liabilities | ||
| Total deferred revenue | 36,700 | 28,900 |
| Takeda Pharmaceuticals Inc | ||
| Contract Assets | ||
| Accounts receivable from related party | 408 | 240 |
| Contract Liabilities | ||
| Deferred revenue, current | 8,780 | 26,231 |
| Deferred revenue, non-current | 441 | 2,670 |
| Total deferred revenue | $ 9,221 | $ 28,901 |
| X | ||||||||||
- Definition Amount of receivables arising from transactions with related parties due within one year or the normal operating cycle, if longer. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as noncurrent. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|